RJFSA
Raymond James Financial Services Advisors’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $111K | Buy |
55,595
+21,769
| +64% | +$43.3K | ﹤0.01% | 3271 |
|
|
2024
Q2 | $118K | Sell |
33,826
-23,140
| -41% | -$81K | ﹤0.01% | 3202 |
|
|
2024
Q1 | $158K | Buy |
56,966
+8,657
| +18% | +$24K | ﹤0.01% | 3148 |
|
|
2023
Q4 | $82.1K | Buy |
48,309
+18,333
| +61% | +$31.2K | ﹤0.01% | 3139 |
|
|
2023
Q3 | $30.9K | Sell |
29,976
-2,974
| -9% | -$3.06K | ﹤0.01% | 3150 |
|
|
2023
Q2 | $38.2K | Buy |
+32,950
| New | +$38.2K | ﹤0.01% | 3139 |
|
|
2023
Q1 | – | Sell |
-12,025
| Closed | -$30.1K | – | 3298 |
|
|
2022
Q4 | $30.1K | Sell |
12,025
-85
| -0.7% | -$213 | ﹤0.01% | 3116 |
|
|
2022
Q3 | $51K | Buy |
12,110
+324
| +3% | +$1.36K | ﹤0.01% | 3075 |
|
|
2022
Q2 | $33K | Sell |
11,786
-25
| -0.2% | -$70 | ﹤0.01% | 3101 |
|
|
2022
Q1 | $68K | Buy |
11,811
+950
| +9% | +$5.47K | ﹤0.01% | 3132 |
|
|
2021
Q4 | $99K | Sell |
10,861
-395
| -4% | -$3.6K | ﹤0.01% | 3108 |
|
|
2021
Q3 | $120K | Sell |
11,256
-265
| -2% | -$2.83K | ﹤0.01% | 3084 |
|
|
2021
Q2 | $179K | Sell |
11,521
-7,550
| -40% | -$117K | ﹤0.01% | 3034 |
|
|
2021
Q1 | $309K | Buy |
19,071
+1,876
| +11% | +$30.4K | ﹤0.01% | 2605 |
|
|
2020
Q4 | $364K | Buy |
17,195
+775
| +5% | +$16.4K | ﹤0.01% | 2335 |
|
|
2020
Q3 | $243K | Sell |
16,420
-5,678
| -26% | -$84K | ﹤0.01% | 2405 |
|
|
2020
Q2 | $325K | Buy |
+22,098
| New | +$325K | ﹤0.01% | 2180 |
|